APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Biomedical

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Artificial Intelligence in Biomedical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 July 2026195 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Biomedical Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Biomedical Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Biomedical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Biomedical Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Biomedical Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Biomedical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Artificial Intelligence in Biomedical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Artificial Intelligence in Biomedical include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Artificial Intelligence in Biomedical market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Intelligence in Biomedical and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Intelligence in Biomedical revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Artificial Intelligence in Biomedical market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Intelligence in Biomedical Segment by Company

AstraZeneca

Thales Group

IBM Corp.

ForeSee Medical

Atomwise

Cloud Pharmaceuticals

GNS Healthcare

Microsoft Corporation

Novartis AG

NVIDIA Corporation

Pfizer

Recursion Pharmaceuticals

XtalPi Inc

Aidoc

AliveCor

GE Healthcare

Imagen Technologies

Vuno Inc.

IDx Technologies Inc.

Siemens Healthcare GmbH

Neural Analytics

Artificial Intelligence in Biomedical Segment by Type

Hardware

Software

Artificial Intelligence in Biomedical Segment by Application

Diagnosing Diseases

Developing Drugs

Personalized Treatment

Other

Artificial Intelligence in Biomedical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Biomedical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Biomedical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Biomedical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Artificial Intelligence in Biomedical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Intelligence in Biomedical industry.

Chapter 3: Detailed analysis of Artificial Intelligence in Biomedical companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Biomedicalrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Hardware Table 3. Key Players of Software Table 4. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Diagnosing Diseases Table 6. Key Players of Developing Drugs Table 7. Key Players of Personalized Treatment Table 8. Key Players of Other Table 9. Global Artificial Intelligence in Biomedical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Artificial Intelligence in Biomedical Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Artificial Intelligence in Biomedical Market Share by Region (2021-2026) Table 12. Global Artificial Intelligence in Biomedical Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Artificial Intelligence in Biomedical Market Share by Region (2027-2032) Table 14. Artificial Intelligence in Biomedical Industry Trends Table 15. Artificial Intelligence in Biomedical Industry Drivers Table 16. Artificial Intelligence in Biomedical Industry Opportunities and Challenges Table 17. Artificial Intelligence in Biomedical Industry Restraints Table 18. Global Artificial Intelligence in Biomedical Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Artificial Intelligence in Biomedical Revenue Market Share by Company (2021-2026) Table 20. Global Artificial Intelligence in Biomedical Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Artificial Intelligence in Biomedical Key Company Head Office and Area Served Table 22. Global Artificial Intelligence in Biomedical Company, Product Type & Application Table 23. Global Artificial Intelligence in Biomedical Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Artificial Intelligence in Biomedical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Artificial Intelligence in Biomedical Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2021-2026) Table 30. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2027-2032) Table 31. Global Artificial Intelligence in Biomedical Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2021-2026) Table 35. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2027-2032) Table 36. AstraZeneca Company Information Table 37. AstraZeneca Business Overview Table 38. AstraZeneca Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. AstraZeneca Artificial Intelligence in Biomedical Product Portfolio Table 40. AstraZeneca Recent Development Table 41. Thales Group Company Information Table 42. Thales Group Business Overview Table 43. Thales Group Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Thales Group Artificial Intelligence in Biomedical Product Portfolio Table 45. Thales Group Recent Development Table 46. IBM Corp. Company Information Table 47. IBM Corp. Business Overview Table 48. IBM Corp. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. IBM Corp. Artificial Intelligence in Biomedical Product Portfolio Table 50. IBM Corp. Recent Development Table 51. ForeSee Medical Company Information Table 52. ForeSee Medical Business Overview Table 53. ForeSee Medical Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio Table 55. ForeSee Medical Recent Development Table 56. Atomwise Company Information Table 57. Atomwise Business Overview Table 58. Atomwise Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Atomwise Artificial Intelligence in Biomedical Product Portfolio Table 60. Atomwise Recent Development Table 61. Cloud Pharmaceuticals Company Information Table 62. Cloud Pharmaceuticals Business Overview Table 63. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 65. Cloud Pharmaceuticals Recent Development Table 66. GNS Healthcare Company Information Table 67. GNS Healthcare Business Overview Table 68. GNS Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 70. GNS Healthcare Recent Development Table 71. Microsoft Corporation Company Information Table 72. Microsoft Corporation Business Overview Table 73. Microsoft Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio Table 75. Microsoft Corporation Recent Development Table 76. Novartis AG Company Information Table 77. Novartis AG Business Overview Table 78. Novartis AG Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Novartis AG Artificial Intelligence in Biomedical Product Portfolio Table 80. Novartis AG Recent Development Table 81. NVIDIA Corporation Company Information Table 82. NVIDIA Corporation Business Overview Table 83. NVIDIA Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio Table 85. NVIDIA Corporation Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Pfizer Artificial Intelligence in Biomedical Product Portfolio Table 90. Pfizer Recent Development Table 91. Recursion Pharmaceuticals Company Information Table 92. Recursion Pharmaceuticals Business Overview Table 93. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio Table 95. Recursion Pharmaceuticals Recent Development Table 96. XtalPi Inc Company Information Table 97. XtalPi Inc Business Overview Table 98. XtalPi Inc Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio Table 100. XtalPi Inc Recent Development Table 101. Aidoc Company Information Table 102. Aidoc Business Overview Table 103. Aidoc Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Aidoc Artificial Intelligence in Biomedical Product Portfolio Table 105. Aidoc Recent Development Table 106. AliveCor Company Information Table 107. AliveCor Business Overview Table 108. AliveCor Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. AliveCor Artificial Intelligence in Biomedical Product Portfolio Table 110. AliveCor Recent Development Table 111. GE Healthcare Company Information Table 112. GE Healthcare Business Overview Table 113. GE Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. GE Healthcare Artificial Intelligence in Biomedical Product Portfolio Table 115. GE Healthcare Recent Development Table 116. Imagen Technologies Company Information Table 117. Imagen Technologies Business Overview Table 118. Imagen Technologies Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio Table 120. Imagen Technologies Recent Development Table 121. Vuno Inc. Company Information Table 122. Vuno Inc. Business Overview Table 123. Vuno Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio Table 125. Vuno Inc. Recent Development Table 126. IDx Technologies Inc. Company Information Table 127. IDx Technologies Inc. Business Overview Table 128. IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio Table 130. IDx Technologies Inc. Recent Development Table 131. Siemens Healthcare GmbH Company Information Table 132. Siemens Healthcare GmbH Business Overview Table 133. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio Table 135. Siemens Healthcare GmbH Recent Development Table 136. Neural Analytics Company Information Table 137. Neural Analytics Business Overview Table 138. Neural Analytics Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Neural Analytics Artificial Intelligence in Biomedical Product Portfolio Table 140. Neural Analytics Recent Development Table 141. North America Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 142. North America Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 143. North America Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 144. North America Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 145. North America Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026) Table 147. North America Artificial Intelligence in Biomedical Market Size by Country (2027-2032) Table 148. Europe Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 149. Europe Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 150. Europe Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 151. Europe Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 152. Europe Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026) Table 154. Europe Artificial Intelligence in Biomedical Market Size by Country (2027-2032) Table 155. China Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 156. China Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 157. China Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 158. China Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 160. Asia Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 161. Asia Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 162. Asia Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Artificial Intelligence in Biomedical Market Size by Country (2021-2026) Table 165. Asia Artificial Intelligence in Biomedical Market Size by Country (2027-2032) Table 166. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2021-2026) & (US$ Million) Table 167. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2027-2032) & (US$ Million) Table 168. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2021-2026) & (US$ Million) Table 169. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2027-2032) & (US$ Million) Table 170. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026) Table 172. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Artificial Intelligence in Biomedical Product Image Figure 2. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Artificial Intelligence in Biomedical Market Share by Type: 2025 VS 2032 Figure 4. Hardware Image Figure 5. Software Image Figure 6. Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Artificial Intelligence in Biomedical Market Share by Application: 2025 VS 2032 Figure 8. Diagnosing Diseases Image Figure 9. Developing Drugs Image Figure 10. Personalized Treatment Image Figure 11. Other Image Figure 12. Global Artificial Intelligence in Biomedical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 14. Global Artificial Intelligence in Biomedical Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Artificial Intelligence in Biomedical Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Artificial Intelligence in Biomedical Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Artificial Intelligence in Biomedical Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Artificial Intelligence in Biomedical Revenue Market Share by Type (2021-2032) Figure 21. Global Artificial Intelligence in Biomedical Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Artificial Intelligence in Biomedical Revenue Market Share by Application (2021-2032) Figure 23. North America Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 24. North America Artificial Intelligence in Biomedical Market Share by Type (2021-2032) Figure 25. North America Artificial Intelligence in Biomedical Market Share by Application (2021-2032) Figure 26. North America Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 27. United States Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 28. Canada Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 30. Europe Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 31. Europe Artificial Intelligence in Biomedical Market Share by Type (2021-2032) Figure 32. Europe Artificial Intelligence in Biomedical Market Share by Application (2021-2032) Figure 33. Europe Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 34. Germany Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 35. France Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 37. Italy Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 38. Russia Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 40. China Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 41. China Artificial Intelligence in Biomedical Market Share by Type (2021-2032) Figure 42. China Artificial Intelligence in Biomedical Market Share by Application (2021-2032) Figure 43. Asia Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 44. Asia Artificial Intelligence in Biomedical Market Share by Type (2021-2032) Figure 45. Asia Artificial Intelligence in Biomedical Market Share by Application (2021-2032) Figure 46. Asia Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 47. Japan Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 51. India Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 52. Australia Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2021-2032) Figure 57. Brazil Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 62. UAE Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 64. Chile Artificial Intelligence in Biomedical Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Diagnosing Diseases
  • Developing Drugs
  • Personalized Treatment
  • Other
Companies covered
  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Artificial Intelligence in Biomedical Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware
  5. 1.2.3 Software
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Artificial Intelligence in Biomedical Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Diagnosing Diseases
  9. 1.3.3 Developing Drugs
  10. 1.3.4 Personalized Treatment
  11. 1.3.5 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Artificial Intelligence in Biomedical Growth Trends by Region
  14. 1.5.1 Global Artificial Intelligence in Biomedical Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Artificial Intelligence in Biomedical Market Size by Region (2021-2026)
  16. 1.5.3 Artificial Intelligence in Biomedical Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Artificial Intelligence in Biomedical Market Dynamics
  1. 2.1 Artificial Intelligence in Biomedical Industry Trends
  2. 2.2 Artificial Intelligence in Biomedical Industry Drivers
  3. 2.3 Artificial Intelligence in Biomedical Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Biomedical Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Artificial Intelligence in Biomedical Revenue by Company (2021-2026)
  2. 3.2 Global Artificial Intelligence in Biomedical Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Artificial Intelligence in Biomedical Key Company Head office and Area Served
  4. 3.4 Global Artificial Intelligence in Biomedical Company, Product Type & Application
  5. 3.5 Global Artificial Intelligence in Biomedical Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Artificial Intelligence in Biomedical Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Artificial Intelligence in Biomedical Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Artificial Intelligence in Biomedical Tier 1, Tier 2, and Tier 3
4 Artificial Intelligence in Biomedical Market by Type
  1. 4.1 Global Artificial Intelligence in Biomedical Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Artificial Intelligence in Biomedical Market Size by Type (2021-2032)
  3. 4.3 Global Artificial Intelligence in Biomedical Market Size Share by Type (2021-2032)
5 Artificial Intelligence in Biomedical Market by Application
  1. 5.1 Global Artificial Intelligence in Biomedical Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence in Biomedical Market Size by Application (2021-2032)
  3. 5.3 Global Artificial Intelligence in Biomedical Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AstraZeneca Artificial Intelligence in Biomedical Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Thales Group
  8. 6.2.1 Thales Group Company Information
  9. 6.2.2 Thales Group Business Overview
  10. 6.2.3 Thales Group Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Thales Group Artificial Intelligence in Biomedical Product Portfolio
  12. 6.2.5 Thales Group Recent Developments
  13. 6.3 IBM Corp.
  14. 6.3.1 IBM Corp. Company Information
  15. 6.3.2 IBM Corp. Business Overview
  16. 6.3.3 IBM Corp. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 IBM Corp. Artificial Intelligence in Biomedical Product Portfolio
  18. 6.3.5 IBM Corp. Recent Developments
  19. 6.4 ForeSee Medical
  20. 6.4.1 ForeSee Medical Company Information
  21. 6.4.2 ForeSee Medical Business Overview
  22. 6.4.3 ForeSee Medical Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 ForeSee Medical Artificial Intelligence in Biomedical Product Portfolio
  24. 6.4.5 ForeSee Medical Recent Developments
  25. 6.5 Atomwise
  26. 6.5.1 Atomwise Company Information
  27. 6.5.2 Atomwise Business Overview
  28. 6.5.3 Atomwise Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Atomwise Artificial Intelligence in Biomedical Product Portfolio
  30. 6.5.5 Atomwise Recent Developments
  31. 6.6 Cloud Pharmaceuticals
  32. 6.6.1 Cloud Pharmaceuticals Company Information
  33. 6.6.2 Cloud Pharmaceuticals Business Overview
  34. 6.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  36. 6.6.5 Cloud Pharmaceuticals Recent Developments
  37. 6.7 GNS Healthcare
  38. 6.7.1 GNS Healthcare Company Information
  39. 6.7.2 GNS Healthcare Business Overview
  40. 6.7.3 GNS Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 GNS Healthcare Artificial Intelligence in Biomedical Product Portfolio
  42. 6.7.5 GNS Healthcare Recent Developments
  43. 6.8 Microsoft Corporation
  44. 6.8.1 Microsoft Corporation Company Information
  45. 6.8.2 Microsoft Corporation Business Overview
  46. 6.8.3 Microsoft Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Microsoft Corporation Artificial Intelligence in Biomedical Product Portfolio
  48. 6.8.5 Microsoft Corporation Recent Developments
  49. 6.9 Novartis AG
  50. 6.9.1 Novartis AG Company Information
  51. 6.9.2 Novartis AG Business Overview
  52. 6.9.3 Novartis AG Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Novartis AG Artificial Intelligence in Biomedical Product Portfolio
  54. 6.9.5 Novartis AG Recent Developments
  55. 6.10 NVIDIA Corporation
  56. 6.10.1 NVIDIA Corporation Company Information
  57. 6.10.2 NVIDIA Corporation Business Overview
  58. 6.10.3 NVIDIA Corporation Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 NVIDIA Corporation Artificial Intelligence in Biomedical Product Portfolio
  60. 6.10.5 NVIDIA Corporation Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Pfizer Artificial Intelligence in Biomedical Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Recursion Pharmaceuticals
  68. 6.12.1 Recursion Pharmaceuticals Company Information
  69. 6.12.2 Recursion Pharmaceuticals Business Overview
  70. 6.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biomedical Product Portfolio
  72. 6.12.5 Recursion Pharmaceuticals Recent Developments
  73. 6.13 XtalPi Inc
  74. 6.13.1 XtalPi Inc Company Information
  75. 6.13.2 XtalPi Inc Business Overview
  76. 6.13.3 XtalPi Inc Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 XtalPi Inc Artificial Intelligence in Biomedical Product Portfolio
  78. 6.13.5 XtalPi Inc Recent Developments
  79. 6.14 Aidoc
  80. 6.14.1 Aidoc Company Information
  81. 6.14.2 Aidoc Business Overview
  82. 6.14.3 Aidoc Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Aidoc Artificial Intelligence in Biomedical Product Portfolio
  84. 6.14.5 Aidoc Recent Developments
  85. 6.15 AliveCor
  86. 6.15.1 AliveCor Company Information
  87. 6.15.2 AliveCor Business Overview
  88. 6.15.3 AliveCor Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 AliveCor Artificial Intelligence in Biomedical Product Portfolio
  90. 6.15.5 AliveCor Recent Developments
  91. 6.16 GE Healthcare
  92. 6.16.1 GE Healthcare Company Information
  93. 6.16.2 GE Healthcare Business Overview
  94. 6.16.3 GE Healthcare Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 GE Healthcare Artificial Intelligence in Biomedical Product Portfolio
  96. 6.16.5 GE Healthcare Recent Developments
  97. 6.17 Imagen Technologies
  98. 6.17.1 Imagen Technologies Company Information
  99. 6.17.2 Imagen Technologies Business Overview
  100. 6.17.3 Imagen Technologies Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Imagen Technologies Artificial Intelligence in Biomedical Product Portfolio
  102. 6.17.5 Imagen Technologies Recent Developments
  103. 6.18 Vuno Inc.
  104. 6.18.1 Vuno Inc. Company Information
  105. 6.18.2 Vuno Inc. Business Overview
  106. 6.18.3 Vuno Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Vuno Inc. Artificial Intelligence in Biomedical Product Portfolio
  108. 6.18.5 Vuno Inc. Recent Developments
  109. 6.19 IDx Technologies Inc.
  110. 6.19.1 IDx Technologies Inc. Company Information
  111. 6.19.2 IDx Technologies Inc. Business Overview
  112. 6.19.3 IDx Technologies Inc. Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 IDx Technologies Inc. Artificial Intelligence in Biomedical Product Portfolio
  114. 6.19.5 IDx Technologies Inc. Recent Developments
  115. 6.20 Siemens Healthcare GmbH
  116. 6.20.1 Siemens Healthcare GmbH Company Information
  117. 6.20.2 Siemens Healthcare GmbH Business Overview
  118. 6.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biomedical Product Portfolio
  120. 6.20.5 Siemens Healthcare GmbH Recent Developments
  121. 6.21 Neural Analytics
  122. 6.21.1 Neural Analytics Company Information
  123. 6.21.2 Neural Analytics Business Overview
  124. 6.21.3 Neural Analytics Artificial Intelligence in Biomedical Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Neural Analytics Artificial Intelligence in Biomedical Product Portfolio
  126. 6.21.5 Neural Analytics Recent Developments
7 North America
  1. 7.1 North America Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 7.2 North America Artificial Intelligence in Biomedical Market Size by Type
  3. 7.2.1 North America Artificial Intelligence in Biomedical Market Size by Type (2021-2026)
  4. 7.2.2 North America Artificial Intelligence in Biomedical Market Size by Type (2027-2032)
  5. 7.2.3 North America Artificial Intelligence in Biomedical Market Share by Type (2021-2032)
  6. 7.3 North America Artificial Intelligence in Biomedical Market Size by Application
  7. 7.3.1 North America Artificial Intelligence in Biomedical Market Size by Application (2021-2026)
  8. 7.3.2 North America Artificial Intelligence in Biomedical Market Size by Application (2027-2032)
  9. 7.3.3 North America Artificial Intelligence in Biomedical Market Share by Application (2021-2032)
  10. 7.4 North America Artificial Intelligence in Biomedical Market Size by Country
  11. 7.4.1 North America Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  13. 7.4.3 North America Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  14. 7.4.4 North America Artificial Intelligence in Biomedical Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 8.2 Europe Artificial Intelligence in Biomedical Market Size by Type
  3. 8.2.1 Europe Artificial Intelligence in Biomedical Market Size by Type (2021-2026)
  4. 8.2.2 Europe Artificial Intelligence in Biomedical Market Size by Type (2027-2032)
  5. 8.2.3 Europe Artificial Intelligence in Biomedical Market Share by Type (2021-2032)
  6. 8.3 Europe Artificial Intelligence in Biomedical Market Size by Application
  7. 8.3.1 Europe Artificial Intelligence in Biomedical Market Size by Application (2021-2026)
  8. 8.3.2 Europe Artificial Intelligence in Biomedical Market Size by Application (2027-2032)
  9. 8.3.3 Europe Artificial Intelligence in Biomedical Market Share by Application (2021-2032)
  10. 8.4 Europe Artificial Intelligence in Biomedical Market Size by Country
  11. 8.4.1 Europe Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  13. 8.4.3 Europe Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  14. 8.4.4 Europe Artificial Intelligence in Biomedical Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 9.2 China Artificial Intelligence in Biomedical Market Size by Type
  3. 9.2.1 China Artificial Intelligence in Biomedical Market Size by Type (2021-2026)
  4. 9.2.2 China Artificial Intelligence in Biomedical Market Size by Type (2027-2032)
  5. 9.2.3 China Artificial Intelligence in Biomedical Market Share by Type (2021-2032)
  6. 9.3 China Artificial Intelligence in Biomedical Market Size by Application
  7. 9.3.1 China Artificial Intelligence in Biomedical Market Size by Application (2021-2026)
  8. 9.3.2 China Artificial Intelligence in Biomedical Market Size by Application (2027-2032)
  9. 9.3.3 China Artificial Intelligence in Biomedical Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 10.2 Asia Artificial Intelligence in Biomedical Market Size by Type
  3. 10.2.1 Asia Artificial Intelligence in Biomedical Market Size by Type (2021-2026)
  4. 10.2.2 Asia Artificial Intelligence in Biomedical Market Size by Type (2027-2032)
  5. 10.2.3 Asia Artificial Intelligence in Biomedical Market Share by Type (2021-2032)
  6. 10.3 Asia Artificial Intelligence in Biomedical Market Size by Application
  7. 10.3.1 Asia Artificial Intelligence in Biomedical Market Size by Application (2021-2026)
  8. 10.3.2 Asia Artificial Intelligence in Biomedical Market Size by Application (2027-2032)
  9. 10.3.3 Asia Artificial Intelligence in Biomedical Market Share by Application (2021-2032)
  10. 10.4 Asia Artificial Intelligence in Biomedical Market Size by Country
  11. 10.4.1 Asia Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  13. 10.4.3 Asia Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  14. 10.4.4 Asia Artificial Intelligence in Biomedical Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Artificial Intelligence in Biomedical Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst